TrialBMC cancer2012

The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancer.

Fiona J Collinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.